Table 1.
Characteristic | No. of patients (%) |
---|---|
Age at diagnosis (years) | |
| |
< 40 | 1 (3.8) |
40-50 | 9 (34.6) |
50-60 | 8 (30.8) |
> 60 | 8 (30.8) |
| |
Years since operation | |
| |
5 | 8 (30.8) |
10 | 15 (57.7) |
15 | 3 (11.5) |
| |
Histological grade | |
| |
1 | 4 (14.8) |
2 | 12 (44.4) |
3 | 10 (37.0) |
N.A.∗ | 1 (3.7) |
| |
Tumour size | |
| |
1 (≤ 2 cm) | 20 (74.1) |
2 (> 2 ≤ 5 cm) | 6 (22.2) |
3 (> 5 cm) | 1 (3.7) |
| |
Oestrogen receptor status | |
| |
Positive | 21 (77.8) |
Negative | 6 (22.2) |
| |
Progesterone receptor status | |
| |
Positive | 16 (59.3) |
Negative | 11 (40.7 |
| |
Her2 status | |
| |
Positive | 2 (7.4) |
Negative | 22 (81.5) |
N.A. | 3 (11.1) |
| |
Lymph node status | |
| |
Positive | 11 (40.7) |
Negative | 16 (59.3) |
| |
Pathologic Characteristics | |
| |
Invasive ductal carcinoma | 22 (81.5) |
Medullary carcinoma | 2 (7.4) |
Invasive lobular carcinoma | 1 (3.7) |
Mixed invasive ductal/lobular carcinoma | 1 (3.7) |
Papillary carcinoma | 1 (3.7) |
| |
Ki67 status | |
| |
Positive | 12 (44.4) |
Negative | 12 (44.4) |
N.A. | 3 (11.1) |
∗ Patient data not available.